mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
0.1 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.1 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.1 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.1 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |